Leonteq Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$762K Sell
1,005
-2,943
-75% -$2.22M 0.03% 271
2026
Q2
$2.46M Buy
3,948
+2,736
+226% +$1.86M 0.08% 154
2026
Q1
$936K Sell
1,212
-130
-10% -$100K 0.03% 305
2025
Q4
$1.04M Sell
1,342
-4,209
-76% -$2.86M 0.03% 318
2025
Q3
$3.12M Buy
5,551
+1,445
+35% +$817K 0.09% 151
2025
Q2
$2.16M Buy
4,106
+301
+8% +$168K 0.08% 152
2025
Q1
$2.37M Buy
3,805
+1,978
+108% +$1.36M 0.13% 142
2024
Q4
$1.3M Buy
1,827
+1,058
+138% +$888K 0.09% 199
2024
Q3
$808K Buy
769
+4
+0.5% +$4.45K 0.06% 244
2024
Q2
$804K Sell
765
-2
-0.3% -$1.94K 0.06% 232
2024
Q1
$738K Sell
767
-173
-18% -$165K 0.06% 262
2023
Q4
$826K Sell
940
-5
-0.5% -$4.12K 0.05% 270
2023
Q3
$778K Sell
945
-1,125
-54% -$884K 0.04% 292
2023
Q2
$1.49M Buy
2,070
+525
+34% +$405K 0.08% 232
2023
Q1
$1.27M Sell
1,545
-1,244
-45% -$938K 0.06% 249
2022
Q4
$2.01M Buy
2,789
+1,268
+83% +$936K 0.07% 191
2022
Q3
$1.05M Sell
1,521
-114
-7% -$71.8K 0.04% 271
2022
Q2
$966K Buy
1,635
+262
+19% +$170K 0.04% 290
2022
Q1
$959K Sell
1,373
-971
-41% -$614K 0.03% 306
2021
Q4
$1.48M Sell
2,344
-292
-11% -$180K 0.05% 262
2021
Q3
$1.6M Sell
2,636
-251
-9% -$156K 0.07% 227
2021
Q2
$1.61M Sell
2,887
-7,183
-71% -$3.64M 0.1% 191
2021
Q1
$4.76M Buy
10,070
+1,908
+23% +$929K 0.28% 83
2020
Q4
$3.94M Buy
+8,162
New +$4.41M 0.21% 94

Other funds holding REGN

Leonteq Securities's REGN Position: Q3 2026 in Review

Leonteq Securities reduced its Regeneron Pharmaceuticals (REGN) stake by 75% in Q3 2026, selling an estimated $2.22M and leaving 1,005 shares worth $762K. The position accounts for 0.03% of the portfolio, ranked #271.

Leonteq Securities first reported a position in REGN in Q4 2020 and has held it in 24 quarters since. The position peaked at $4.76M in Q1 2021. 1,431 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Leonteq Securities held 1,005 shares of Regeneron Pharmaceuticals worth $762K as of Q3 2026.
  • Leonteq Securities sold 2,943 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $2.22M.
  • Regeneron Pharmaceuticals made up 0.03% of Leonteq Securities's portfolio in Q3 2026, its #271 holding.
  • Leonteq Securities first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
  • Leonteq Securities's Regeneron Pharmaceuticals position peaked at $4.76M in Q1 2021.
  • 1,431 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.